Duloxetine 60 mg qd

DRUG2 trials

Sponsors

Boehringer Ingelheim, Southeastern Regional Medical Center

Conditions

Chemotherapy-Induced Peripheral NeuropathyDepressive Disorder, MajorDiabetic Neuropathies

Phase 2

Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Southeastern Regional Medical CenterChemotherapy-Induced Peripheral Neuropathy

Start: 2019-06-30End: 2021-10-31Target: 50Updated: 2019-04-04

Phase 4

Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder

CompletedNCT00844194

Boehringer IngelheimDepressive Disorder, Major, Diabetic Neuropathies

Start: 2009-02-28Updated: 2014-05-15